Ginkgo Bioworks reports Q1 2026 revenue decline after biosecurity sale

May 7, 2026 4:05 PM

Ginkgo Bioworks Holdings Inc. (NYSE: DNA) reported first quarter 2026 revenue of $19 million, down 49% from $38 million in ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found